← Back to Clinical Trials
Recruiting NCT05603000

NCT05603000 Emotion Focused Family Therapy for Parents of Children With Mental Health Difficulties

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05603000
Status Recruiting
Phase
Sponsor University of Guelph
Condition Anxiety
Study Type INTERVENTIONAL
Enrollment 200 participants
Start Date 2022-10-11
Primary Completion 2027-03

Eligibility & Interventions

Sex All sexes
Min Age 7 Years
Max Age 15 Years
Study Type INTERVENTIONAL
Interventions
Emotion Focused Family Therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 200 participants in total. It began in 2022-10-11 with a primary completion date of 2027-03.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Emotion Focused Family Therapy (EFFT) is a promising intervention that aims to teach parents advanced skills to support their child's development of emotion skills and increase their adaptive behaviours, potentially leading to improvements in their child's psychological functioning and family functioning more broadly. This randomized controlled trial (RCT; EFFT vs waitlist control) will (1) test the efficacy of a 6-week group EFFT program on parent and child outcomes and (2) examine maintenance of treatment gains up to four months post-intervention.

Eligibility Criteria

Inclusion Criteria: * Parent of child aged 7 to 15 years old with anxiety, depression, or behavioural challenges * Parent of child is willing to participate in intervention * Parent is living at home with the child Exclusion Criteria: * Parent or child not proficient enough in speaking/understanding English to complete measures or EFFT intervention components * Parent or child with a severe mental health disorder (e.g., active suicidality and psychosis) is not considered suitable for the trial intervention due to the clinical need for immediate intervention * Parent or child is actively receiving, or due to receive, intensive psychological intervention focused on cognitive and/or behavioural strategies to intervene with emotional or behavioural difficulties * Parent or child has any disabilities in language, speech or hearing that would interfere with their completion of the EFFT and measures * Parent or child are allergic to adhesive electrode gel use in some tasks (i.e., sodium chloride)

Contact & Investigator

Central Contact

Kristel Thomassin, Ph.D

✉ kristel.thomassin@uoguelph.ca

📞 519-824-4120

Principal Investigator

Kristel Thomassin, Ph.D

PRINCIPAL INVESTIGATOR

University of Guelph

Frequently Asked Questions

Who can join the NCT05603000 clinical trial?

This trial is open to participants of all sexes, aged 7 Years or older, up to 15 Years, studying Anxiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05603000 currently recruiting?

Yes, NCT05603000 is actively recruiting participants. Contact the research team at kristel.thomassin@uoguelph.ca for enrollment information.

Where is the NCT05603000 trial being conducted?

This trial is being conducted at Guelph, Canada.

Who is sponsoring the NCT05603000 clinical trial?

NCT05603000 is sponsored by University of Guelph. The principal investigator is Kristel Thomassin, Ph.D at University of Guelph. The trial plans to enroll 200 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology